Videos and Podcasts

31st Jan 22

Investor briefing - 31 January 2022

Pharmaxis Ltd (ASX: PXS) released its Quarterly Shareholder Update on the morning of 31 January 2022.

Investors and analysts joined the Company for a virtual investor briefing by chief executive officer Mr Gary Phillips.

The event consisted of a short presentation of the Company’s progress over the past quarter and future plans followed by a Q&A session from attendees. You can watch a recording of the presentation below.

Watch recording here

8th Dec 21

Investor Briefing - 8 December 2021

On 8 Dec 2021, Pharmaxis Ltd (ASX: PXS) held a virtual investor briefing with the Company’s chief executive officer Mr Gary Phillips. The event featured a short presentation of the Company’s recent progress and future plans post capital raising followed by a Q&A session from attendees.

Watch recording here.

9th Nov 21

Pharmaxis receives approval for phase 2 study of its cancer drug in liver cancer

Pharmaxis CEO Gary Phillips speaks to Proactive following the news an Investigational New Drug application for a trial of PXS‐5505 in hepatocellular carcinoma (HCC) patients has been cleared by the FDA. The IND was submitted by the University of Rochester Medical Center following positive pre‐clinical results reported in August.

Watch the interview here